Patent classifications
A61L24/0084
MINIMALLY INVASIVE TREATMENT OF VERTEBRA (MITV) USING A CALCIUM PHOSPHATE COMBINATION BONE CEMENT
Featured are a biocompatible, injectable, self-setting, cohesive, bone-bonding and remodeling calcium phosphate composite material and its use in methods of repairing defective bone, e.g., in vertebroplasty augmentation and kyphoplasty.
NONABSORBABLE SETTABLE MULTI-PUTTY BONE CEMENTS, HEMOSTATIC COMPOSITIONS AND METHODS OF USE
Provided herein are settable, nonabsorbable bone hemostatic and adhesive compositions for use in surgical procedures comprising a variety of disclosed particles. Also provided are related compositions, including surgical kits and packages, as well as methods of making and using the compositions.
Bone treatment systems and methods
The present disclosure relates to bone cement formulations that have an extended working time for use in vertebroplasty procedures and other osteoplasty procedures together with cement injectors that include energy delivery systems for on-demand control of cement viscosity and flow parameters. The bone cement formulations may include a liquid component having at least one monomer and a non-liquid component including polymer particles and benzoyl peroxide (BPO). The non-liquid component may be further configured to allow controlled exposure of the BPO to the liquid monomer so as to enable control of the viscosity of the bone cement composition.
ORGANOPHOSPHOROUS, MULTIVALENT METAL COMPOUNDS, & POLYMER ADHESIVE INTERPENETRATING NETWORK COMPOSITIONS & METHODS
Certain small molecule amino acid phosphate compounds such as phosphoserine and certain multivalent metal compounds such as calcium phosphate containing cements have been found to have improved properties and form an interpenetrating network in the presence of a polymer that contains either an electronegative carbonyl oxygen atom of the ester group or an electronegative nitrogen atom of the amine group as the bonding sites of the polymer surfaces to the available multivalent metal ions.
ABSORBABLE COMPOSITIONS AND METHODS FOR THEIR USE IN HEMOSTASIS
The present invention is direct to a body-absorbable, mechanically hemostatic composition comprising a solid poloxamer having an average molecular weight of about 7,000 g/mol to about 15,000 g/mol, a high molecular weight dextran, optionally a fatty acid salt, and water, and a method for mechanically controlling the bleeding of bone comprising applying an effective amount of the composition to the affected area.
ABSORBABLE COMPOSITIONS AND METHODS FOR THEIR USE IN HEMOSTASIS
The present invention is direct to a body-absorbable, mechanically hemostatic composition comprising a solid poloxamer having an average molecular weight of about 7,000 g/mol to about 15,000 g/mol, a high molecular weight dextran, optionally a fatty acid salt, and water, and a method for mechanically controlling the bleeding of bone comprising applying an effective amount of the composition to the affected area.
Injectable, biodegradable bone cements and methods of making and using same
Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.
Injectable, biodegradable bone cements and methods of making and using same
Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.
Injectable, biodegradable bone cements and methods of making and using same
Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.
Injectable, biodegradable bone cements and methods of making and using same
Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.